Connection
Michael Szarek to Inflammation Mediators
This is a "connection" page, showing publications Michael Szarek has written about Inflammation Mediators.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.046 |
|
|
|
-
Kinlay S, Schwartz GG, Olsson AG, Rifai N, Sasiela WJ, Szarek M, Ganz P, Libby P. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study. Circulation. 2004 Jul 27; 110(4):386-91.
Score: 0.046